Characterizing the Frequency of Pharmacogenomic Biomarker-Guided Prescribing for Drugs with Pharmacogenomic Biomarker information in the FDA Labelling: A Pilot Study Using Data from an Electronic Health Record.

Patrick Mathias Emily Beth Devine Maher Khelifi Katelyn Keyloun Nathaniel Hendrix Patrick Mathias Christian Bock Peter Tarczy-Hornoch Characterizing the Frequency of Pharmacogenomic Biomarker-Guided Prescribing for Drugs with Pharmacogenomic Biomarker information in the FDA Labelling: A Pilot Study Using Data from an Electronic Health Record. 2015 AMIA https://knowledge.amia.org/59310-amia-1.2741865/t001-1.2745946/f001-1.2745947/2249076-1.2746179/2246270-1.2746176 conf/amia/2015 db/conf/amia/amia2015.html#DevineKKHMBT15 Christian Bock Emily Beth Devine Nathaniel Hendrix Katelyn Keyloun Maher Khelifi Peter Tarczy-Hornoch